| Financial Year |
March 31 2023 |
| Monetary Funds |
106,791,036.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,481,623.00 |
| Accounts Receivable |
232,367,983.89 |
| Advances to Suppliers |
5,178,009.29 |
| Other Receivables |
1,630,203.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
329,861,917.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
350,939,974.64 |
| Total Current Assets |
1,034,250,748.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
179,000.08 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
206,900,062.95 |
| Under-construction Projects |
1,240,672.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,346,393.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,876,089.89 |
| Deferred Income Tax Assets |
23,643,964.80 |
| Other Non-Current Assets |
7,913,349.50 |
| Sub-Total of Non-Current Assets |
304,089,430.97 |
| Total Assets |
1,338,340,179.83 |
| Short-Term Loans |
128,131,579.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
340,000,000.00 |
| Accounts Payable |
130,340,716.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,984,378.06 |
| Taxes Payable |
2,844,490.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
963,296,890.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
9,844,744.12 |
| Sub-Total of Current Liabilities |
1,624,520,923.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,671,722.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,767,463.14 |
| Total Liabilities |
1,630,288,386.64 |
| Paid-In Capital(Or Share Stock) |
687,815,040.00 |
| Capital Surplus |
500,352,900.29 |
| Surplus Reserve |
42,818,214.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,522,187,541.95 |
| Minority Stockholder's Interest |
4,004,630.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-295,952,837.10 |
| Owner's Equity（Stockholder's Equity） |
-291,948,206.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,338,340,179.83 |
